Role of oxidative and antioxidative parameters in etiopathogenesis and prognosis of panic disorder

International Journal of Neuroscience

Volumn 118, Issue 7, 2008, Pages 1025-1037

  Ersoy, Mehmet Akif ^a   Selek, Salih ^b   Celik, Hakim ^c   Erel, Ozcan ^c   Kaya, Mehmet Cemal ^b   Savas, Haluk A ^b   Herken, Hasan ^d  

^a EGE UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c HARRAN UNIVERSITY   (Turkey)

^d PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Antioxidant activity; Ceruloplasmin; Free radical; Oxidative stress; Panic disorder; Sulphydryl

Indexed keywords

CERULOPLASMIN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL DISEASE; OXIDATIVE STRESS; PANIC; PATHOGENESIS; PROGNOSIS;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; BRAIN; BRAIN CHEMISTRY; CERULOPLASMIN; ENERGY METABOLISM; FEMALE; FREE RADICALS; HUMANS; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; PANIC DISORDER; PROGNOSIS; SULFUR COMPOUNDS; UP-REGULATION;

EID: 45849139343     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450701769026     Document Type: Article

References (27)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders. 4th edn. Washington, DC: American Psychiatric Association.
2. Atmaca, M., Tezcan, E., Kuloglu, M., Ustundag, B., & Tunckol, H. (2004). Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. European Archives of Psychiatry and Clinical Neuroscience, 254(4), 231-235.
3. Attari, A., Asgary, S., Naderi, G. A., & Rezayat, A. (2002). Lipid peroxidation and antioxidant capacity in posttraumatic stress disorder. Journal of Isfahan Medical School, 20, 4-6.
4. Bandelow, B. (1995). Assessing the efficacy of treatment of panic disorder and agoraphobia, II. The panic and agoraphobia scale. International Clinical Psychopharmacology, 10(2), 73-81.
5. Bilici, M., Efe, H., Koroglu, M. A., Uydu, H. A., Bekaroglu, M., & Deger, O. (2001). Antioxidative enzyme activities and lipid peroxidation inmajor depression: Alterations by antidepressant treatments. Journal of Affective Disorders, 64(1), 43-51.
6. Burton, G. W., & Ingold, K. U. (1989). Vitamin E as an in vitro and in vivo antioxidant. Annals of the New York Academy of Sciences, 570, 7-22.
7. Cao, G., & Prior, R. L. (1998). Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clinical Chemistry, 44, 1309-1315.
8. Ellman, G. L. (1959). Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics, 82(1), 70-77.
9. Erel, O. (1998). Automated measurement of serum ferroxidase activity. Clinical Chemistry, 44(11), 2313-2319.
10. Erel,O. (2004). Anovel automatedmethod to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry, 37(2), 112-119.
11. Erel, O. (2005). A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry, 38(12), 1103-1111.
12. Gergerlioglu, H. S., Savas, H. A., Bulbul, F., Selek, S., Uz, E., & Yumru, M. (2007). Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Prog Neuropsychopharmacol. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31(3), 697-702.
13. Halliwell, B., & Gutteridge, J. M. (1990). Antioxidants of human extracellular fluids. Archives of Biochemistry and Biophysics, 280(1), 1-8.
14. Herken, H., Akyol, O., Yilmaz, H. R., Tutkun, H., Savas, H. A., Ozen, M. E., Kalenderoglu, A., & Gulec, M. (2006). Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: Alterations by antidepressant treatment. Human Psychopharmacology, 21(1), 53-59.
15. Herken, H., Uz, E., Ozyurt, H., Sogut, S., Virit, O., & Akyol, O. (2001). Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Molecular Psychiatry, 6(1), 66-73.
16. Horoz, M., Bolukbas, C., Bolukbas, F. F., Aslan,M., Koylu, A. O., Selek, S., & Erel, O. (2006). Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infectious Diseases, 6, 114.
17. Hu, M. L., Louie, S., Cross, C. E., Motchnik, P., & Halliwell, B. (1993). Antioxidant protection against hypochlorous acid in human plasma. The Journal of Laboratory and Clinical Medicine, 121(2), 257-262.
18. Khanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R. (2003). Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep, 8(6), 365-370.
19. Kuloglu, M., Atmaca, M., Tezcan, E., Gecici, O., Tunckol, H., & Ustundag, B. (2002a). Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology, 46(1), 27-32.
20. Kuloglu, M., Atmaca, M., Tezcan, E., Ustundag, B., & Bulut, S. (2002b). Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology, 46(4), 186-189.
21. Kuloglu, M., Ustundag, B., Atmaca, M., Canatan, H., Tezcan, E., & Cinkilinc, N. (2002c). Lipid peroxidation and antioxidant enzyme levels of patients with schizophrenia and bipolar disorder. Cell Biochemistry and Function, 20(2), 171-175.
22. Leff, J. A. (1994). Autoimmune and inflammatory diseases. In D. Armstrong (Ed.), Free radicals in diagnostic medicine. (pp. 199-213). New York: Plenum Press.
23. Mahadik, S. P., & Mukherjee, S. (1996). Free radical pathology and antioxidant defence in schizophrenia: A review. Schizophrenia Research, 19(1), 1-17.
24. Savas, H. A., Gergerlioglu, H. S., Armutcu, F., Herken, H., Yilmaz, H. R., Kocoglu, E., Selek, S., Tutkun, H., Zoroglu, S. S., & Akyol, O. (2006). Elevated serum nitric oxide and superoxide dismutase in euthymic bipolarpatients: Impact of past episodes. The World Journal of Biological Psychiatry, 7(1), 51-55.
25. Savas, H. A., Herken, H., Yurekli, M., Uz, E., Tutkun, H., Zoroglu, S. S., Ozen, M. E., Cengiz, B., & Akyol, O. (2002). Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology, 45(2), 57-61.
26. Stadtman, E. R. (1992). Protein oxidation and aging. Science, 257(5074), 1220-1224.
27. Tezcan, E., Atmaca, M., Kuloglu, M., & Ustundag, B. (2003). Free radicals in patients with post-traumatic stress disorder. European Archives of Psychiatry and Clinical Neuroscience, 253(2), 89-91.